Zynerba Pharmaceuticals Inc. - Wikirate, an Open ESG Data Platform

RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact

arrow_back_ios

Research Groups

arrow_forward_ios

Home
Companies
Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc.

performance profile

WikiRate ID: 3034248

Headquarters: Pennsylvania (United States)

Answers 116
Sources 9
Groups 1
Data Sets 0
Details

Filters

Answers

116

Metrics

23

Years

10

Sort

2022

US Securities and Exchange Commission+Image

55.5M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Effective Income Tax Rate Continuing Operations

0

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Income Loss From Continuing Operations Before Income Taxes Foreign

-1.73M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

9.29M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

-35M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Operating Expenses

35.3M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Operating Income (Loss)

-35.3M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Prepaid Insurance

1.55M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Research and Development Expense

21.1M USD

Open in full page

Open in new window

2021

80 W. LANCASTER AVENUE, DEVON, 19333

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Net Income Attributable to the company

-37.3M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

81.2M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Effective Income Tax Rate Continuing Operations

0

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Income Loss From Continuing Operations Before Income Taxes Foreign

-2.58M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

10.3M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

-37.3M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Operating Expenses

36.8M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Operating Income (Loss)

-36.8M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Prepaid Insurance

1.95M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Research and Development Expense

21.4M USD

Open in full page

Open in new window

1
2
3
...
6

1 - 20 of 116

Export Toggle Dropdown

Export Data

Format

Detail

Answers

Cancel

Applying Attribution

Using this data requires appropriate attribution.

How to attribute

Wikirate, an initiative of Wikirate International e.V., is an open data platform powered by its community.

legal

Wikirate Policies Privacy Policy Terms of Use Impressum

contact

Contact us on Wikirate international Subscribe for Updates

follow us

We're on Decko

WikiRate's content is licensed under CC BY 4.0, and the database infrastructure under CC BY-SA 4.0. Read more about licensing.